(Press-News.org) MINNEAPOLIS (May 15, 2013) —Death rates associated with patients with refractory angina, or chronic chest pain, are lower than previously considered; therefore, physicians should focus on relieving the chest pain symptoms and improving the quality of life in these patients according to an article published online this week in the European Heart Journal.
Refractory angina patients endure ongoing chest pain despite optimal medical management and for them, standard revascularization techniques, such as surgery or stenting, is no longer an option. Traditionally, these are the patients with the most advanced coronary artery disease, frequently referred to as "no-option patients."
"Importantly, this study describes the first long-term results from the largest and most contemporary follow-up of patients in a dedicated refractory angina clinic," says the study's first author Timothy D. Henry, MD, director of research at the Minneapolis Heart Institute Foundation. "Our results demonstrate that long-term mortality in patients with refractory angina is surprisingly low, below 4 percent per year."
The OPtions In Myocardial Ischemic Syndrome Therapy (OPTIMIST) program at the Minneapolis Heart Institute® at Abbott Northwestern Hospital in Minneapolis was created for refractory angina patients in 1996 to develop new treatment options for this challenging patient population. This study reflects the long-term survival and predictors of mortality.
The study population consisted of 1,200 consecutive patients with either refractory myocardial ischemia and/or refractory angina, who were not candidates for traditional revascularization and referred for alternative treatment strategies from 1996 to present.
Overall, 241 patients of the 1,200 died during a median follow-up of 5.1 years. After an analysis, the researchers determined mortality was 3.9 percent at one year and 28.4 percent at nine years.
"Currently, data on the incidence and prevalence of refractory angina are scarce and mainly derived from registries," explains Henry.
In addition to the low overall mortality, the results indicated non-cardiac death in nearly 30 percent of patients and a low incidence of sudden cardiac death.
Improved secondary prevention strategies, evidence-based medical therapy and more advanced revascularization techniques all likely contributed to lower mortality, concluded Henry and his colleagues in the paper.
"Widespread and improved adherence to medical medications combined with aggressive lifestyle changes, such as diet, exercise and smoking cessation, has contributed to lower overall mortality in patients with coronary artery disease, and this includes the highest-risk patients with refractory angina," Henry notes.
Based on the findings, more than 70 percent of patients with refractory angina can expect to survive nine years from the time of diagnosis. Given these results, the researchers emphasized that therapeutic options for this growing population should therefore focus on chest pain relief and improved quality of life.
###
Jon Holden DeHaan Foundation supported the study.
Minneapolis Heart Institute Foundation
The Minneapolis Heart Institute Foundation is dedicated to creating a world without heart disease through groundbreaking clinical research and innovative education programs. MHIF's mission is to promote and improve cardiovascular health, quality of life and longevity for all.
Minneapolis Heart Institute®
The Minneapolis Heart Institute® is recognized internationally as one of the world's leading providers of heart and vascular care. This state-of-the-art facility combines the finest in personalized patient care with sophisticated technology in a unique, family-oriented environment. The Institute's programs, a number of which are conducted in conjunction with Abbott Northwestern Hospital, address the full range of heart and vascular health needs: prevention, diagnosis, treatment and rehabilitation.
Contact Information:
Steve Goodyear
Minneapolis Heart Institute Foundation
sgoodyear@mhif.org
612-863-1658
http://mplsheart.org
Long-term outcomes in patients with advanced coronary artery disease are better than expected
2013-05-16
ELSE PRESS RELEASES FROM THIS DATE:
PARP inhibitor shows activity in pancreatic, prostate cancers among patients carrying BRCA mutations
2013-05-16
PHILADELPHIA – In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced pancreatic and prostate cancers. Results of the study, led by researchers from the Perelman School of Medicine at the University of Pennsylvania and Sheba Medical Center in Tel Hashomer, Israel, will be presented during the American Society of Clinical Oncology's annual meeting in Chicago in early June (Abstract #11024).
The multi-center ...
Penn medicine study finds broad support for rationing of some types of cancer care
2013-05-16
PHILADELPHIA – The majority of cancer doctors, patients, and members of the general public support cutting health care costs by refusing to pay for drugs that don't improve survival or quality of life, according to results of a new study that will be presented by researchers from the Perelman School of Medicine at the University of Pennsylvania during the annual meeting of the American Society of Clinical Oncology in Chicago in early June (Abstract #6518).
The Penn Medicine team surveyed 326 adult cancer patients receiving treatment at Penn's Abramson Cancer Center, a ...
UIC information specialists ease switch to new healthcare codes
2013-05-16
University of Illinois at Chicago researchers have developed a website that walks healthcare providers through the challenging transition from the current International Classification of Diseases -- ICD-9 -- to the new ICD-10.
Doctors, hospitals and all other healthcare providers have until October 2014 to switch to the new coding system, used to classify every disease or condition and in every aspect of healthcare from ordering supplies to insurance reimbursement.
The switch won't be easy -- the number of codes has grown from 14,000 to 68,000. The AMA estimates the ...
Canada must addess real climate-change challenge
2013-05-16
To reach Canada's goal of reducing greenhouse gas (GHG) emissions to 17 per cent below the 2005 level by the year 2020, federal and provincial governments, led by the Prime Minister and provincial premiers, must reach agreement on what portion of the total GHG reduction will be provided by each province say researchers from the University of Toronto's School of the Environment. Their report is being sent to all Canadian federal and provincial governments, opposition parties and other participants in the climate policy dialogue.
"Canadian governments have always known ...
Clam fossils divulge secrets of ecologic stability
2013-05-16
ITHACA, N.Y. - Clam fossils from the middle Devonian era – some 380 million years ago – now yield a better paleontological picture of the capacity of ecosystems to remain stable in the face of environmental change, according to research published today (May 15) in the online journal PLOS ONE.
Trained to examine species abundance – the head counts of specimens – paleontologists test the stability of Earth's past ecosystems. The research shows that factors such as predation and organism body size from epochs-gone-by can now be considered in such detective work.
Back 380 ...
Vitamin C does not lower uric acid levels in gout patients
2013-05-16
Despite previous studies touting its benefit in moderating gout risk, new research reveals that vitamin C, also known ascorbic acid, does not reduce uric acid (urate) levels to a clinically significant degree in patients with established gout. Vitamin C supplementation, alone or in combination with allopurinol, appears to have a weak effect on lowering uric acid levels in gout patients according to the results published in the American College of Rheumatology (ACR) journal, Arthritis & Rheumatism.
Gout is an inflammatory arthritis that causes excruciating pain and swelling ...
Natural 'keystone molecules' punch over their weight in ecosystems
2013-05-16
Naturally occurring "keystone" molecules that have powerful behavioral effects on diverse organisms often play large but unrecognized roles in structuring ecosystems, according to a theory proposed in the June issue of BioScience. The authors of the theory, Ryan P. Ferrer of Seattle Pacific University and Richard K. Zimmer of the University of California at Los Angeles, liken such molecules to keystone species, animals or plants that may be uncommon but exert a controlling influence, through predation or in other ways. Keystone molecules function in chemical communication ...
Doctor Who Celebrates 50th Anniversary at Vivid Sydney
2013-05-16
NSW Deputy Premier and Minister for Trade and Investment, Andrew Stoner, today announced Vivid Sydney 2013 will feature a spectacular celebration of the 50th Anniversary of the legendary BBC television program, Doctor Who.
Stoner said that June 1, the grand façade of Customs House at Circular Quay will showcase an amazing visual feast of 3D-mapped projections of Doctor Who as he travels through space and time, pursued by some of his greatest enemies.
"This is a one-night only celebration of the 50th Anniversary of Doctor Who, and sees Australian creative innovators, ...
Brookfield's Encinitas Community Seaside Ridge to Grand Open May 18
2013-05-16
On Saturday, May 18 at 10 a.m., Brookfield Residential will grand open Seaside Ridge, an intimate community of 23 semi-custom residences in Encinitas. The community is located at 809 Dolphin Circle and will offer homes priced from the low $1 millions.
During the grand opening, guests can tour Seaside Ridge's 2,883 square-foot model home and view floor plan and customization offerings.
"Seaside Ridge's intimate location and limited number of homes make it unlike other new home communities throughout the county," said Rocky Tracy, VP of Sales for Brookfield ...
Annodyne Celebrates Another Landmark Year of Growth and Accomplishment
2013-05-16
Marking their 11-year anniversary, Annodyne unveiled a new brand in early 2012, repositioning itself as a leader in "engagement marketing" — a revolutionary approach to marketing through which a target audience is nurtured in one-to-one fashion, through every phase of its lifecycle. In addition to a new logo, tagline and positioning, Annodyne's revamped identity included a new office space to accommodate a nearly doubled workforce and a redesigned website that reflects the new brand.
On the client front, Annodyne put their expertise as a full-service marketing ...